The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 29, 2019

Filed:

Sep. 25, 2015
Applicants:

F. Hoffmann-la Roche Ag, Basel, CH;

Genentech, Inc., South San Francisco, CA (US);

Inventors:

Francis Gosselin, South San Francisco, CA (US);

Chong Han, South San Francisco, CA (US);

Hans Iding, Basel, CH;

Reinhard Reents, Basel, CA (US);

Scott Savage, South San Francisco, CA (US);

Beat Wirz, Basel, CH;

Assignees:

GENENTECH INC., South San Francisco, CA (US);

F. HOFFMANN-LA ROCHE AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 239/70 (2006.01); C07D 239/54 (2006.01); C07D 239/42 (2006.01); C07C 253/30 (2006.01); C07C 255/22 (2006.01); C07B 57/00 (2006.01); C12P 41/00 (2006.01); C07C 253/34 (2006.01); C12N 9/78 (2006.01);
U.S. Cl.
CPC ...
C07D 239/70 (2013.01); C07B 57/00 (2013.01); C07C 253/30 (2013.01); C07C 253/34 (2013.01); C07C 255/22 (2013.01); C07D 239/42 (2013.01); C07D 239/54 (2013.01); C12N 9/78 (2013.01); C12P 41/00 (2013.01); C12Y 305/05001 (2013.01); C07B 2200/07 (2013.01);
Abstract

The present disclosure relates to processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, and more particularly relates to processes for preparing (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d] pyrimidin-4-yl)piperazine and N-protected derivatives thereof, which may be used as an intermediate in the synthesis of Ipatasertib (i.e., (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)-propan-1-one). The present disclosure additionally relates to various compounds that are intermediates employed in these processes.


Find Patent Forward Citations

Loading…